# ClinicalTrials.gov record NCT07443956

> PeptideScanner retained ClinicalTrials.gov record NCT07443956 at 2026-07-30T16:19:36.909Z. Its registry update date was 2026-05-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct07443956-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-05-04
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07443956-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07443956-tirzepatide-v1.json
- Content SHA-256: `5852a2b019282ef8c6b113a8ded702b042c8acde55ba0518479dc782a76d1a58`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07443956 ([`ctg-observation-nct07443956-2026-05-04-eaf3920a4ee9`](#source-ctg-observation-nct07443956-2026-05-04-eaf3920a4ee9))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07443956 at 2026-07-30T16:19:36.909Z. Its registry update date was 2026-05-04, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct07443956-2026-05-04-eaf3920a4ee9`](#source-ctg-observation-nct07443956-2026-05-04-eaf3920a4ee9))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07443956 at 2026-07-30T16:19:36.909Z. Its registry update date was 2026-05-04, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct07443956-2026-05-04-eaf3920a4ee9`](#source-ctg-observation-nct07443956-2026-05-04-eaf3920a4ee9))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07443956-2026-05-04-eaf3920a4ee9`](#source-ctg-observation-nct07443956-2026-05-04-eaf3920a4ee9))

## Sources

<a id="source-ctg-observation-nct07443956-2026-05-04-eaf3920a4ee9"></a>
- **ClinicalTrials.gov record NCT07443956 · retained source version 2026-05-04:eaf3920a4ee9ffbe0994754233f17dff260314d8273e6388632740d91a9f332f** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07443956) (`ctg-observation-nct07443956-2026-05-04-eaf3920a4ee9`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07443956." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07443956-tirzepatide-v1.json SHA-256: 5852a2b019282ef8c6b113a8ded702b042c8acde55ba0518479dc782a76d1a58.